As of 17 Sept 2026, Fortis Healthcare Ltd share price is ₹888.45. The stock opened at ₹888.45 and had closed at ₹868.50 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹767.30 and a high of ₹1,105.00. In terms of performance, Fortis Healthcare Ltd share price has increased by 2.70% over the past six months and has decreased by 10.30% over the last year.
FORTIS Stock Price Chart
Fortis Healthcare Ltd Overview
About FORTIS
Fortis Healthcare is a leading integrated healthcare delivery service provider. The Company is primarily engaged in the business of healthcare services. The Company also holds interests in its subsidiaries, associates and joint ventures which manage and operate a network of multi-specialty hospitals and diagnostics centers.
Fortis Healthcare Ltd Historical Performance
FORTIS Futures & Options
Fortis Healthcare Ltd Fundamentals
Fortis Healthcare Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 1,957.68 | 1,644.44 | 1,324.42 | 1,202.50 | 996.71 |
| EBITDA | 593.35 | 338.92 | 429.46 | 331.00 | 233.22 |
| Net Profit | 230.34 | 63.79 | 199.45 | 96.24 | -13.25 |
| EPS | 3.05 | 0.84 | 2.64 | 1.27 | -0.18 |
Fortis Healthcare Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 860.85 |
| Resistance 1 (R1) | 877.75 |
| Pivot Point | 870.10 |
Fortis Healthcare Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 24-Jul-2026 | 22-May-2026 | 24-Jul-2026 | Final | ₹1.00 |
| 25-Jul-2025 | 20-May-2025 | 25-Jul-2025 | Final | ₹1.00 |
| 24-Jul-2024 | 23-May-2024 | 24-Jul-2024 | Final | ₹1.00 |
| 20-Jul-2023 | 24-May-2023 | 20-Jul-2023 | Final | ₹1.00 |
FORTIS Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Leo Puri | Chairman |
| Ashutosh Raghuvanshi | Managing Director & Chief Executive Officer |
| DILIP KADAMBI | Non Executive Independent Director |
Fortis Healthcare Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,744.50+0.55% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,028.50+0.34% | ₹1,02,534.79 | 72.27 | 13.42% |
| Narayana Hrudayalaya LtdNH | ₹1,872.00+1.10% | ₹35,563.89 | 45.64 | 17.76% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Fortis Healthcare Ltd today is ₹888.45 on NSE and ₹888.45 on BSE.
- The 52-week high of Fortis Healthcare Ltd is ₹1,105.00, while the 52-week low is ₹767.30.
- The current market capitalisation of Fortis Healthcare Ltd is approximately ₹65,568 crore.
- The P/E (Price-to-Earnings) ratio of Fortis Healthcare Ltd is 70.10. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Fortis Healthcare Ltd is 7.29. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Fortis Healthcare Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for FORTIS on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Fortis Healthcare Ltd has delivered a return of approximately 163.02%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Fortis Healthcare Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 31.17% promoters, -0.61% FIIs, 32.23% DIIs, and 9.87% public shareholders.

